# Pepton Health reviews (2026): GLP-1 telehealth sellers | This GLP The two cheaper products are sold as GLP-1 without saying which one, and refill pricing needs an account. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/pepton-health Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Two cards name no drug # Pepton Health review The two cheaper products are sold as GLP-1 without saying which one, and refill pricing needs an account. ## The verdict Pepton Health publishes starting figures of $179 for an injection, $99 for a tablet and $299 for tirzepatide. Only the third names its molecule. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Injection From $179/mo Oral From $99/mo Prescription Required Compounded Yes — not FDA-approved Pepton Health sells three products: a weekly injection, a daily dissolvable tablet and a tirzepatide injection. Two are described only as GLP-1. 1. ## Who writes the prescription, and what do they see? A prescription is issued before dispensing. The cards describe a schedule rather than a clinician. Naming a category instead of a drug makes the two cheaper products hard to compare against anything. Refill pricing sitting behind account creation compounds it. 2. ## What happens when the dose goes up? Every figure is a starting price and none states a dose. The refill rate, which is the one that matters after month one, requires an account to see. 3. ## What the price includes Six months from $179 is $1,074 and from $99 is $594, if the starting figures hold past the first fill. Whether they do is the question account creation is standing in front of. 4. ## What it claims, and what it cites The lines are compounded. A pharmacy prepares them. No agency reviews a compounded preparation before it is dispensed, and the unnamed molecule question sits on top of that. ## Where it holds up, and where it does not - Strength: Three distinct products carry a figure - Strength: The tirzepatide card names its drug - Strength: A tablet route is priced openly - Limitation: Two cards name no molecule - Limitation: Refill pricing needs an account - Limitation: Every figure is a starting price - Limitation: The states served are not listed ## What the evidence says about this kind of treatment The assessment above is about Pepton Health. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who will create an account before deciding anything. Wrong for A reader who wants to know which drug they are buying from the storefront. ## The evidence behind what Pepton Health prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Pepton Health compares | Seller | Who it suits | Go | | --- | --- | --- | | Silhouette MD | Readers who want an unqualified number and will pay the tablet premium for one | | | Somi Health | Readers who want the dose question answered in writing before anything else | | | Corsica Health | Readers who want the monthly rate and the prepay discount on one selector | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [RegenCen](https://thisglp.com/reviews/regencen) [Rese Wellness](https://thisglp.com/reviews/rese-wellness) [Revive Longevity](https://thisglp.com/reviews/revive-longevity) [Rila](https://thisglp.com/reviews/rila) [Risen Labs](https://thisglp.com/reviews/risen-labs) [Robinhood Telehealth](https://thisglp.com/reviews/robinhood-telehealth) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What drug does $179 actually buy? The card does not say. It reads GLP-1 Injections. What does a refill cost? The refill pricing sits behind account creation. Is the tablet the same drug? The card names no molecule for it either. Is Pepton Health expensive compared with other GLP-1 telehealth sellers? Pepton Health publishes a starting figure of $99/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Pepton Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).